Newsbenzinga
SeaStar Medical Reports 65.1% Survival Rate At Day 90 In Its QUELIMMUNE SAVE Registry Analysis Presented At ASN Kidney Week 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…